Cargando…

Histone antibodies as a biomarker of uveitis in JIA

Detalles Bibliográficos
Autores principales:	Nordal, Ellen B, Berntson, Lillemor, Aalto, Kristiina, Fasth, Anders, Herlin, Troels, Nielsen, Susan, Peltoniemi, Suvi, Zak, Marek, Rygg, Marite
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4184152/ http://dx.doi.org/10.1186/1546-0096-12-S1-O4

Ejemplares similares

Prognostic factors for the disease course and 8-year outcome in Nordic children with oligoarticular-onset juvenile idiopathic arthritis
por: Peltoniemi, Suvi, et al.
Publicado: (2014)

Anti-type II collagen antibodies, anti-CCP, IgA RF and IgM RF are associated with joint damage, assessed eight years after onset of juvenile idiopathic arthritis (JIA)
por: Berntson, Lillemor, et al.
Publicado: (2014)

Incidence and predictors of Uveitis in juvenile idiopathic arthritis in a Nordic long-term cohort study
por: Nordal, Ellen, et al.
Publicado: (2017)

Psoriasis and associated variables in classification and outcome of juvenile idiopathic arthritis - an eight-year follow-up study
por: Ekelund, Maria, et al.
Publicado: (2017)

Fatigue in young adults with juvenile idiopathic arthritis 18 years after disease onset: data from the prospective Nordic JIA cohort
por: Arnstad, Ellen Dalen, et al.
Publicado: (2021)

Ongoing disease-activity and change in ILAR categories in a Nordic juvenile idiopathic arthritis cohort
por: Nordal, Ellen, et al.
Publicado: (2012)

Complement lectin pathway protein levels reflect disease activity in juvenile idiopathic arthritis: a longitudinal study of the Nordic JIA cohort
por: Glerup, Mia, et al.
Publicado: (2019)

Juvenile arthritis disease activity score (JADAS) based on C-reactive protein predicts DMARD treatment in juvenile idiopathic arthritis in a Nordic multicenter cohort
por: Nordal, Ellen, et al.
Publicado: (2012)

Predicting unfavorable long-term outcome in juvenile idiopathic arthritis: results from the Nordic cohort study
por: Rypdal, Veronika, et al.
Publicado: (2018)

Ankle arthritis predicts worse outcome in children with juvenile idiopathic arthritis
por: Esbjörnsson, Anna-Clara, et al.
Publicado: (2014)

Participation in school and physical education in juvenile idiopathic arthritis in a Nordic long-term cohort study
por: Nordal, Ellen, et al.
Publicado: (2019)

Transitioning patients with juvenile idiopathic arthritis to adult care: the Nordic experience
por: Mikola, Katriina, et al.
Publicado: (2022)

PReS-FINAL-2046: Uveitis in the Nordic juvenile idiopathic arthritis cohort; high incidence, frequent complications, and gender-associated risk factors
por: Nordal, EB, et al.
Publicado: (2013)

PReS-FINAL-2071: Anti-type II collagen antibodies, anti-CCP, IgA-RF and IgM-RF are associated with joint damage eight years after onset of juvenile idiopathic arthritis (JIA)
por: Berntson, L, et al.
Publicado: (2013)

Validation of prediction models of severe disease course and non-achievement of remission in juvenile idiopathic arthritis: part 1—results of the Canadian model in the Nordic cohort
por: Rypdal, Veronika, et al.
Publicado: (2019)

Juvenile Arthritis Disease Activity Score (JADAS) based on CRP; validity and predictive ability in a Nordic population-based setting
por: Nordal, EB, et al.
Publicado: (2011)

Non-HLA genepolymorphisms in juvenile chronic arthritis: associations with outcome of disease
por: Alberdi-Saugstrup, Mikel, et al.
Publicado: (2014)

M-ficolin: a valuable biomarker to identify leukaemia from juvenile idiopathic arthritis
por: Brix, Ninna, et al.
Publicado: (2022)

HLA-B27 predicts a more extended disease with increasing age at onset in boys with juvenile idiopathic arthritis
por: Berntson, L, et al.
Publicado: (2008)

May antihistone antibodies replace antinuclear antibodies (ANA) as a predictor of uveitis in Juvenile idiopathic arthritis?
por: Nordal, EB, et al.
Publicado: (2008)

A novel serum calprotectin (MRP8/14) particle-enhanced immuno-turbidimetric assay (sCAL turbo) helps to differentiate systemic juvenile idiopathic arthritis from other diseases in routine clinical laboratory settings
por: Foell, Dirk, et al.
Publicado: (2023)

Ultrasonography (US) in juvenile idiopathic arthritis (JIA): diagnosis, treatment and follow-up of ankle involvement
por: Laurell, L, et al.
Publicado: (2008)

4.4 Different phenotype of anaemia in systemic juvenile idiopathic arthritis (s-JIA) compared to anaemia in other subtypes of JIA
por: Hinze, CH, et al.
Publicado: (2008)

To evaluate the impact of a nurse-led JIA education program on parental satisfaction regarding knowledge of JIA and its management
por: Jones, J, et al.
Publicado: (2011)

Adalimumab and severe uveitis in juvenile idiopathic arthritis (JIA) therapy
por: Alpigiani, MG, et al.
Publicado: (2008)

Infliximab to treat chronic uveitis in juvenile idiopathic arthritis (JIA)
por: Bracaglia, C, et al.
Publicado: (2008)

KIR-HLA class I combinations in JIA-associated uveitis
por: Parsa, Miriam, et al.
Publicado: (2012)

Proposal for a definition for response to treatment, inactive disease and damage for JIA associated uveitis based on the validation of a uveitis related JIA outcome measures from the Multinational Interdisciplinary Working Group for Uveitis in Childhood (MIWGUC)
por: Foeldvari, Ivan, et al.
Publicado: (2019)

IL-18 production upon s100 stimulation is reduced in active sJIA patients compared to sJIA patients in remission and healthy controls
por: Haar, Nienke Ter, et al.
Publicado: (2014)

Correction to: Proposal for a definition for response to treatment, inactive disease and damage for JIA associated uveitis based on the validation of a uveitis related JIA outcome measures from the Multinational Interdisciplinary Working Group for Uveitis in Childhood (MIWGUC)
por: Foeldvari, Ivan, et al.
Publicado: (2020)

The effects of early aggressive therapy in JIA: results of the TREAT study
por: Wallace, Carol A, et al.
Publicado: (2012)

Sport and exercise habits in children with juvenile idiopathic arthritis (JIA)
por: Nørgaard, M, et al.
Publicado: (2011)

Disease characteristics of HLA-B27 positive and negative finnish patients with juvenile idiopathic arthritis - results of the 18-year cohort follow-up study
por: Peltoniemi, Suvi Oili Orvokki, et al.
Publicado: (2023)

Rituximab in ANA positive polyarticular juvenile idiopathic arthritis (JIA) with uveitis
por: Baildam, EM, et al.
Publicado: (2008)

Psychological Effects and Quality of Life in Parents and Children with Jia-Associated Uveitis
por: Guerriero, Silvana, et al.
Publicado: (2022)

Serious infections in JIA patients upon MTX, TFN inhibitors and combinations
por: Horneff, Gerd, et al.
Publicado: (2014)

Safety and efficacy of varicella vaccination in children with JIA treated with biologic therapy
por: Toplak, Natasa, et al.
Publicado: (2014)

Mandibular condyle destruction in juvenile idiopathic arthritis (JIA)
por: Zak, M, et al.
Publicado: (2008)

14.4 Oligoarticular Juvenile Idiopathic Arthritis (JIA): can extension be predicted?
por: Hunter, PJ, et al.
Publicado: (2008)

Adalimumab treatment in Juvenile Idiopathic Arthritis (JIA) patients with special focus on Uveitis
por: Joos, R, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_mehnagcuhta55nu4n7gklms0jh